IDEAYA BIOSCIENCES INC's ticker is IDYA and the CUSIP is 45166A102. A total of 83 filers reported holding IDEAYA BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,799,865 | +243.6% | 437,356 | +199.3% | 0.00% | +200.0% |
| Q2 2023 | $3,433,726 | +109.8% | 146,116 | +22.6% | 0.00% | – |
| Q1 2023 | $1,636,657 | -23.8% | 119,203 | +0.9% | 0.00% | -100.0% |
| Q4 2022 | $2,146,567 | +56.8% | 118,138 | +28.8% | 0.00% | – |
| Q3 2022 | $1,369,000 | +9.2% | 91,704 | +1.0% | 0.00% | – |
| Q2 2022 | $1,254,000 | +30.9% | 90,819 | +6.1% | 0.00% | – |
| Q1 2022 | $958,000 | -51.5% | 85,572 | +2.5% | 0.00% | -100.0% |
| Q4 2021 | $1,974,000 | -6.9% | 83,463 | +0.3% | 0.00% | 0.0% |
| Q3 2021 | $2,121,000 | +53.9% | 83,185 | +26.7% | 0.00% | – |
| Q2 2021 | $1,378,000 | +33.8% | 65,636 | +49.8% | 0.00% | – |
| Q1 2021 | $1,030,000 | +87.6% | 43,822 | +11.8% | 0.00% | – |
| Q4 2020 | $549,000 | +11.4% | 39,208 | 0.0% | 0.00% | – |
| Q3 2020 | $493,000 | +33.6% | 39,208 | +51.2% | 0.00% | – |
| Q2 2020 | $369,000 | – | 25,923 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners X LLC | 2,660,713 | $29,774,000 | 30.23% |
| Logos Global Management LP | 2,850,000 | $31,892,000 | 4.14% |
| 5AM Venture Management, LLC | 1,398,066 | $15,644,000 | 3.42% |
| ACT CAPITAL MANAGEMENT, LLC | 173,500 | $1,941,000 | 2.05% |
| DAFNA Capital Management LLC | 490,061 | $5,484,000 | 1.43% |
| Boxer Capital, LLC | 2,202,812 | $24,649,000 | 1.27% |
| BVF INC/IL | 1,600,559 | $17,910,000 | 0.72% |
| Avidity Partners Management LP | 2,690,000 | $30,101,000 | 0.63% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 62,929 | $704,000 | 0.43% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 109,000 | $1,623,000 | 0.37% |